BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1050 related articles for article (PubMed ID: 28302134)

  • 21. HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis.
    Sun Y; Chen H; Dai J; Zou H; Gao M; Wu H; Ming B; Lai L; Xiao Y; Xiong P; Xu Y; Gong F; Zheng F
    J Neuroimmunol; 2015 Mar; 280():29-35. PubMed ID: 25773152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
    Papaneophytou CP; Georgiou E; Karaiskos C; Sargiannidou I; Markoullis K; Freidin MM; Abrams CK; Kleopa KA
    Glia; 2018 Dec; 66(12):2589-2603. PubMed ID: 30325069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-142a-3p and miR-155-5p reduce methamphetamine-induced inflammation: Role of the target protein Peli1.
    Yu G; Song Y; Xie C; Tao L; Wan F; Jiang L; Wang J; Tang J
    Toxicol Appl Pharmacol; 2019 May; 370():145-153. PubMed ID: 30914375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
    Al-Ghezi ZZ; Miranda K; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2019; 10():1921. PubMed ID: 31497013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling.
    Liu X; Zhou F; Yang Y; Wang W; Niu L; Zuo D; Li X; Hua H; Zhang B; Kou Y; Guo J; Kong F; Pan W; Gao D; Meves JM; Sun H; Xue M; Zhang Q; Wang Y; Tang R
    Glia; 2019 Jan; 67(1):101-112. PubMed ID: 30294880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
    Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
    J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
    Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
    J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
    J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulated RNA-Induced Silencing Complex (RISC) Assembly within CNS Corresponds with Abnormal miRNA Expression during Autoimmune Demyelination.
    Lewkowicz P; Cwiklińska H; Mycko MP; Cichalewska M; Domowicz M; Lewkowicz N; Jurewicz A; Selmaj KW
    J Neurosci; 2015 May; 35(19):7521-37. PubMed ID: 25972178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-7188-5p and miR-7235 regulates Multiple sclerosis in an experimental mouse model.
    Ibrahim HM; AlZahrani A; Hanieh H; Ahmed EA; Thirugnanasambantham K
    Mol Immunol; 2021 Nov; 139():157-167. PubMed ID: 34543842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
    Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
    J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity.
    Berard JL; Kerr BJ; Johnson HM; David S
    Glia; 2010 Nov; 58(15):1816-26. PubMed ID: 20645407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
    Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
    J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of taurine-up-regulated gene 1 attenuates inflammation by sponging miR-9-5p via targeting NF-κB1/p50 in multiple sclerosis.
    Yue P; Jing L; Zhao X; Zhu H; Teng J
    Life Sci; 2019 Sep; 233():116731. PubMed ID: 31394128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis.
    Zhang J; Cheng Y; Cui W; Li M; Li B; Guo L
    J Neuroimmunol; 2014 Jan; 266(1-2):56-63. PubMed ID: 24332164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
    Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
    Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
    Yao SQ; Li ZZ; Huang QY; Li F; Wang ZW; Augusto E; He JC; Wang XT; Chen JF; Zheng RY
    J Neurochem; 2012 Oct; 123(1):100-12. PubMed ID: 22639925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
    Polak PE; Lin SX; Pelligrino D; Feinstein DL
    J Neuroimmunol; 2014 Nov; 276(1-2):135-41. PubMed ID: 25242632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.